Targeting RNA modifications in leukaemia: Epitranscriptomic drugs are the new kids on the block BRIT J HAEMATOL
Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma J Clin Invest
Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide Leukemia
Novel prognostic factors and therapeutic advances in adult acute lymphoblastic leukemia LEUKEMIA LYMPHOMA
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023 Hematol Oncol
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab Blood Cancer J
Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes HAEMATOLOGICA